Key facts
- It has raised $133.8M across 2 recorded rounds; the latest was Seed Round ($1.9M) in Jul 2019.
- Notable investors include Aldrich Capital Partners, Current Yield with Participation Fund, Petrichor Healthcare Capital Management.
- Persivia has filed 2 Form Ds with the SEC, most recently Aug 2019 ($3.1M sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Persivia
Funding rounds
2 roundsAbout Persivia
Developer of a SaaS-based chronic care management platform designed to help providers personalize patient care and improve outcomes. The company's platform merges clinical, socioeconomic and claims data to provide a single comprehensive picture that puts the patient at the center of care and offers advanced analytics, real-time clinical decision support and valuable insights into enhancing care and reducing costs, enabling doctors and hospitals to manage government regulations and population risk through one robust platform.
- Sector
- Healthcare
- HQ
- Marlborough, MA, United States
- Founded
- 2005
- Employees
- 106
- Website
- persivia.com/
- Ownership
- Privately Held (backing)
Persivia doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Persivia shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Persivia in its N-PORT filings yet. We sweep new filings monthly.